With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
Share
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
CROCS Turns OT Cyber Policy Into Action
Air Force tracks a 100-point OT cyber plan, convenes 100 experts monthly and pushes bases to rehearse operations through cyber disruptions.
13m watch -
From Fax Machines to AI: Health Agencies Accelerate Modernization
HRSA and CMS officials outlined plans to replace legacy transplant systems, automate prior authorization and expand AI-assisted care.
3m read -
IHS is Positioning Cybersecurity as Patient Safety
IHS CISO Benjamin Koshy explains why cybersecurity is critical to patient safety and how the agency secures care delivery in remote areas.
7m watch -
DLA CIO: Securing AI Pipelines Is Now a Core Mission
With small vendors comprising most of its supplier base, Roberts says stronger oversight and zero-trust controls are critical to counter cyber threats.
6m watch
